Ideas

October 27, 2017

Published by admin_auro at October 27, 2017

Categories

Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Lucidone, Asprin, and Sulforaphane (LAS) isolated from Lindera erythrocarpa Makino, Meadowsweet, and Broccoli, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 28/October/2017, 12.10 am

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]

October 27, 2017

Published by admin_auro at October 27, 2017

Categories

Ideas
Stroke

Molecular therapy for Stroke: Vildagliptin, an anti-hyperglycemic medication, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 28/October/2017, 12.01 am

Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; […]

October 26, 2017

Published by admin_auro at October 26, 2017

Categories

Molecular therapy for attenuating pathogenesis of Myocardial infarction: Lobeglitazone, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 27/October/2017, 12.55 am

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems […]

October 26, 2017

Published by admin_auro at October 26, 2017

Categories

Small molecule-based GPC2 pathway blockade enhances the efficacy of Cancer immunotherapy in Neuroblastoma: A therapeutic mix encompassing Shikonin, Idasanutlin, Rhamnetin, and Cisplatin [SIRC] inhibits the expression of GPC2, increases IFNγ signalling, increases antigen presentation and unfolding response, increases Cytotoxic activity of T-cells, inhibits neuroblastoma proliferation, decreases tumor burden and increases survival via up-regulation of its target gene, 27/October/2017, 12.46 am

Introduction:What they say: A recent study from Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA […]